Evidence map›Paper›PMID 34539349›Full record

ReviewFrontiers in cellular neuroscience2021

Use of Radical Oxygen Species Scavenger Nitrones to Treat Oxidative Stress-Mediated Hearing Loss: State of the Art and Challenges.

Isabel Varela-Nieto, Silvia Murillo-Cuesta, Lourdes Rodríguez-de la Rosa, María Jesús Oset-Gasque, José Marco-Contelles

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. α-Phenyl-Antioxidants (Basel, Switzerland) · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Isabel Varela-NietoInstitute for Biomedical Research "Alberto Sols," Spanish National Research Council (CSIC)-Autonomous University of Madrid, Madrid, Spain.
Silvia Murillo-CuestaInstitute for Biomedical Research "Alberto Sols," Spanish National Research Council (CSIC)-Autonomous University of Madrid, Madrid, Spain.
Lourdes Rodríguez-de la RosaInstitute for Biomedical Research "Alberto Sols," Spanish National Research Council (CSIC)-Autonomous University of Madrid, Madrid, Spain.
María Jesús Oset-GasqueDepartment of Biochemistry and Molecular Biology, School of Pharmacy, Complutense University of Madrid, Madrid, Spain.
José Marco-ContellesLaboratory of Medicinal Chemistry, Institute of General Organic Chemistry, CSIC, Madrid, Spain.
Instituto de Investigaciones Biomédicas Sols-Morreale · ESCentre for Biomedical Network Research on Rare Diseases · ESInstituto de Química Orgánica General · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitrones are potent antioxidant molecules able to reduce oxidative stress by trapping reactive oxygen and nitrogen species. The antioxidant potential of nitrones has been extensively tested in multiple models of human diseases. Sensorineural hearing loss has a heterogeneous etiology, genetic alterations, aging, toxins or exposure to noise can cause damage to hair cells at the organ of Corti, the hearing receptor. Noxious stimuli share a battery of common mechanisms by which they cause hair cell injury, including oxidative stress, the generation of free radicals and redox imbalance. Therefore, targeting oxidative stress-mediated hearing loss has been the subject of much attention. Here we review the chemistry of nitrones, the existing literature on their use as antioxidants and the general state of the art of antioxidant treatments for hearing loss.

Indexed as

4-OHPBNantioxidantsfree radicalsN-acetyl-L-cysteineNXY-059PBNsensorineural hearing loss

Identifiers

PMID34539349
PMCPMC8440819
OpenAlexW3197724310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.